The coronavirus vaccine approved for use in Russia appears safe and triggered immune responses in tested adults, although the shot may not be as potent as those being advanced by Moderna, Pfizer and AstraZeneca, according to data published Friday in The Lancet.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,